TY  - JOUR
AU  - Gordo Remartínez , Susana
AU  - Calderón Moreno, María
AU  - Fernández Herranz, Juan
AU  - Castuera Gil, Ana
AU  - Gallego Alonso-Colmenares, María Del Mar
AU  - Puertas López, Carolina
AU  - Nuevo González, José Antonio
AU  - Sánchez Sendín, Domingo
AU  - García Gámiz, Mercedes
AU  - Sevillano Fernández, José Antonio
AU  - Álvarez Sala, Luis A.
AU  - Andueza Lillo, Juan Antonio
AU  - Salas Álvarez, Jesús De La Ascensión
AU  - Miguel Yanes, José María De
PY  - 2015
DO  - 10.1371/journal.pone.0125212
UR  - https://hdl.handle.net/20.500.14352/92664
T2  - PLoS One
AB  - Backgroundmidregional proadrenomedullin (MR-proADM) is a prognostic biomarker in patients with community-acquired pneumonia (CAP). We sought to confirm whether MR-proADM added to Pneumonia Severity Index (PSI) improves the potential prognostic value...
LA  - eng
M2  - e0125212
PB  - Public Library of Science
KW  - Adverse events
KW  - Medical risk factors
KW  - Critical care and emergency medicine
KW  - Pneumonia
KW  - Forecasting
KW  - Death rates
KW  - Hospitals
KW  - Biomarkers
TI  - Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia
TY  - journal article
VL  - 10
ER  -